GlycoMark® is the only blood test that specifically indicates recent hyperglycemia in patients with diabetes. The GlycoMark test provides a clinically proven one- to two-week measure of glycemic excursions, often related to post prandial sugar spikes.
The GlycoMark test is a CE-marked and FDA cleared test that provides quantitative measurement of 1,5-anhydroglucitol (1,5-AG) in serum or plasma. The test is for professional use, and is not intended to diagnose any specific diabetes state or disease. Since its discovery, over 40 clinical trials have been completed using the marker around the world. GlycoMark, Inc. is a joint venture among Toyota Tsusho America, Inc. (New York, NY), Toyota Tsusho Corporation (Tokyo, Japan) and Nippon Kayaku Co., Ltd. (Tokyo, Japan) and is dedicated to the discovery and commercialization of novel biomarkers for diabetes. Visit www.glycomark.com.
Product Categories
- Blood Glucose Monitoring